V-4020

N/A

Report date: 2025/07/29 20:00:11

Base Information

Drug NameV-4020
Drug Alias Namevenezuelan equine encephalitis virus vaccine (live attenuated) (Medigen/University of Louisville)V-4020
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccineVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Live attenuated vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsEncephalomyelitis, Venezuelan Equine
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Louisville
China Registration ClassN/A

Develop Information

Active CompaniesMedigen IncUniversity Of Louisville
Inactive CompaniesN/A
Active IndicationsEncephalomyelitis, Venezuelan Equine
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A